Article
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
24 Jul 2018
Abstract excerpt
Drug resistance is a major cause for therapeutic failure in non-small cell lung cancer (NSCLC) leading to tumor recurrence and disease progression. Cell intrinsic mechanisms of resistance include changes in the expression of drug transporters, activation of pro-survival, and anti-apoptotic pathways, as well as non-intrinsic influences of the tumor microenvironment. It has become evident that tumors are composed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
